Literature DB >> 12502173

Imported furuncular myiasis in Germany.

Leon Robert1, John Yelton.   

Abstract

Furuncular myiasis is a parasitic infestation of human and other vertebrate tissues by fly larvae of primarily two species: Dermatobia hominis (human botfly, t6rsalo, or berne) in Mexico and South and Central America and Cordylobia anthropophaga (tumbu fly or mango fly) in Africa. Cuterebra species (rabbit and rodent botflies) are also rarely reported to cause furuncular myiasis only within the United States. Although these species inhabit different geographic regions and have different life cycles, their clinical presentations can be similar. We describe a case of "imported" human botfly (D. hominis) furuncular myiasis in a U.S. Army soldier stationed in Germany. We review the life cycles of human botflies and key aspects of their clinical presentation, differential diagnosis, and various therapeutic modalities. Most physicians may never encounter myiasis and attribute a patient's complaints to an insect bite or skin infection that will heal without treatment. However, the diagnosis of furuncular myiasis should be considered by remembering the basic elements of this condition: recent travel history to the tropics and a sterile, persistent furuncle with sensations of movement and pain.

Entities:  

Mesh:

Year:  2002        PMID: 12502173

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  3 in total

1.  Cutaneous myiasis caused by Cordylobia anthropophaga.

Authors:  Jernej Logar; Barbara Soba; Zlatko Parac
Journal:  Wien Klin Wochenschr       Date:  2006-04       Impact factor: 1.704

Review 2.  Cutaneous Myiasis.

Authors:  Michal Solomon; Tamar Lachish; Eli Schwartz
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

Review 3.  The Botfly, A Tropical Menace: A Distinctive Myiasis Caused by Dermatobia hominis.

Authors:  Sara D Ragi; Rajendra Kapila; Robert A Schwartz
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.